Nicholas G LaRocca
Overview
Explore the profile of Nicholas G LaRocca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
1034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hittle M, Culpepper W, Langer-Gould A, Marrie R, Cutter G, Kaye W, et al.
JAMA Neurol
. 2023 May;
80(7):693-701.
PMID: 37184850
Importance: Racial, ethnic, and geographic differences in multiple sclerosis (MS) are important factors to assess when determining the disease burden and allocating health care resources. Objective: To calculate the US...
2.
Goldman M, LaRocca N, Rudick R, Hudson L, Chin P, Francis G, et al.
Neurology
. 2019 Oct;
93(21):e1921-e1931.
PMID: 31641014
Objective: We report analyses of a pooled database by the Multiple Sclerosis Outcome Assessments Consortium to evaluate 4 proposed components of a multidimensional test battery. Methods: Standardized data on 12,776...
3.
Wojcik C, Beier M, Costello K, DeLuca J, Feinstein A, Goverover Y, et al.
Mult Scler
. 2019 Oct;
25(14):1848-1869.
PMID: 31637963
Background: The proliferation of computerized neuropsychological assessment devices (CNADs) for screening and monitoring cognitive impairment is increasing exponentially. Previous reviews of computerized tests for multiple sclerosis (MS) were primarily qualitative...
4.
Culpepper W, Marrie R, Langer-Gould A, Wallin M, Campbell J, Nelson L, et al.
Neurology
. 2019 Feb;
92(10):e1016-e1028.
PMID: 30770432
Objective: To develop a valid algorithm for identifying multiple sclerosis (MS) cases in administrative health claims (AHC) datasets. Methods: We used 4 AHC datasets from the Veterans Administration (VA), Kaiser...
5.
Wallin M, Culpepper W, Campbell J, Nelson L, Langer-Gould A, Marrie R, et al.
Neurology
. 2019 Feb;
92(10):e1029-e1040.
PMID: 30770430
Objective: To generate a national multiple sclerosis (MS) prevalence estimate for the United States by applying a validated algorithm to multiple administrative health claims (AHC) datasets. Methods: A validated algorithm...
6.
Nelson L, Wallin M, Marrie R, Culpepper W, Langer-Gould A, Campbell J, et al.
Neurology
. 2019 Feb;
92(10):469-480.
PMID: 30770422
Objective: Considerable gaps exist in knowledge regarding the prevalence of neurologic diseases, such as multiple sclerosis (MS), in the United States. Therefore, the MS Prevalence Working Group sought to review...
7.
Strober L, DeLuca J, Benedict R, Jacobs A, Cohen J, Chiaravalloti N, et al.
Mult Scler
. 2018 Oct;
25(13):1781-1790.
PMID: 30334474
Background: The need for more robust outcomes in multiple sclerosis (MS) clinical trials has been a main priority of the field for decades. Dissatisfaction with existing measures has led to...
8.
Halpern M, Kane H, Teixeira-Poit S, Ford C, Giesser B, Halper J, et al.
Int J MS Care
. 2018 Mar;
20(1):35-43.
PMID: 29507541
Background: Anecdotal reports suggest shortages among neurologists who provide multiple sclerosis (MS) patient care. However, little information is available regarding the current and future supply of and demand for this...
9.
LaRocca N, Hudson L, Rudick R, Amtmann D, Balcer L, Benedict R, et al.
Mult Scler
. 2017 Aug;
24(11):1469-1484.
PMID: 28799444
Background: The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) was formed by the National MS Society to develop improved measures of multiple sclerosis (MS)-related disability. Objectives: (1) To assess the current...
10.
Motl R, Mowry E, Ehde D, LaRocca N, Smith K, Costello K, et al.
Mult Scler
. 2017 Jan;
24(3):262-267.
PMID: 28080254
Background: People with multiple sclerosis (MS) have identified "wellness" and associated behaviors as a high priority based on "social media listening" undertaken by the National MS Society (i.e. the Society)....